132 hedge funds and large institutions have $564M invested in Genmab in 2019 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 41 increasing their positions, 27 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
132
Holders Change
+35
Holders Change %
+36.08%
% of All Funds
2.61%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
49
Increased
41
Reduced
27
Closed
13
Calls
$8K
Puts
Net Calls
+$8K
Net Calls Change
+$8K
Name Holding Trade Value Shares
Change
Shares
Change %
MAM
126
Meeder Asset Management
Ohio
$1K +$1K +57 New
OPS
127
Orion Portfolio Solutions
Nebraska
$1K +$1K +59 New
SPIA
128
Steward Partners Investment Advisory
New York
$1K +$1K +65 New
FCH
129
Freestone Capital Holdings
Washington
$407 +$47 +2,093 +13%
HM
130
HealthCor Management
New York
-$14.1M -696,835 Closed
SIG
131
Senator Investment Group
New York
-$6.58M -325,000 Closed
UBS AM
132
UBS AM
Illinois
-$4.9M -241,703 Closed
OMC
133
Old Mission Capital
Illinois
-$4.22M -208,363 Closed
Jane Street
134
Jane Street
New York
-$3.71M -182,955 Closed
DIM
135
DC Investments Management
Virginia
-$669K -33,003 Closed
T. Rowe Price Associates
136
T. Rowe Price Associates
Maryland
-$438K -21,613 Closed
OAM
137
Oxford Asset Management
United Kingdom
-$381K -18,830 Closed
Cerity Partners
138
Cerity Partners
New York
-$250K -12,340 Closed
BL
139
Balentine LLC
Georgia
-$11K -529 Closed
CCA
140
Catalyst Capital Advisors
New York
-$6K -315 Closed
TRCT
141
Tower Research Capital (TRC)
New York
-$1K -50 Closed